Impact of protease polymorphisms and viral fitness on human immunodeficiency virus (HIV) type 1 viremia in untreated HIV-1 infection [2]

Journal of Infectious Diseases

Volumn 185, Issue 12, 2002, Pages 1844-1846

  Märki, Yvonne ^a   Kaufmann, Gilbert R ^a   Battegay, Manuel ^a   Klimkait, Thomas ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEINASE;

DNA POLYMORPHISM; ENZYME ANALYSIS; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD;

ADULT; ENDOPEPTIDASES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MUTATION; PILOT PROJECTS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; VIRAL LOAD; VIREMIA;

EID: 0037097655     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340842     Document Type: Letter

References (6)

1. Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy
2. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
3. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study
4. Dissecting the mode of action of various HIV-inhibitor classes in a stable cellular system
5. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
6. Impact of amino acid insertions in p6 identified in patients with failure of combination ART: Alterations in Vpr incorporation and virus maturation